{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:30:17Z","timestamp":1772850617183,"version":"3.50.1"},"reference-count":19,"publisher":"SLACK, Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmic Surg Lasers Imaging Retina"],"published-print":{"date-parts":[[2015,9]]},"abstract":"\n BACKGROUND AND OBJECTIVE:<\/jats:title>\n To explore characteristics associated with cystoid macular edema (CME) in neonates screened for retinopathy of prematurity (ROP).<\/jats:p>\n <\/jats:sec>\n \n PATIENTS AND METHODS:<\/jats:title>\n In this institutional review board-approved, prospective, observational study, premature neonates underwent imaging with handheld spectral-domain optical coherence tomography.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n Of 73 included infants (median gestational age [GA]: 28 weeks, range 23\u201333 weeks; birth weight: 966 g, range 506 g \u2013 1695 g), 28 (38%) had CME and 17\/28 (61%) had ROP. CME was associated with ROP (\n P<\/jats:italic>\n = .03) and younger GA (\n P<\/jats:italic>\n = .04), but not associated with sex, race, birth weight, postmenstrual age at imaging, ROP severity, or myopia at median 6 months corrected age. CME resolved in three cases after bevacizumab treatment for type 1 ROP and in five cases without treatment. CME appeared in two cases several weeks following injections.\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n CME was associated with ROP and younger GA, but not with myopia. Intravitreal bevacizumab for type 1 ROP has inconclusive effects on CME.<\/jats:p>\n \n \n [\n Ophthalmic Surg Lasers Imaging Retina<\/jats:italic>\n . 2015;46:806\u2013812.]\n <\/jats:bold>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3928\/23258160-20150909-04","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T18:46:28Z","timestamp":1443811588000},"page":"806-812","source":"Crossref","is-referenced-by-count":13,"title":["The Characteristics and Short-term Refractive Error Outcomes of Cystoid Macular Edema in Premature Neonates as Detected by Spectral-Domain Optical Coherence Tomography"],"prefix":"10.3928","volume":"46","author":[{"given":"Sailaja","family":"Bondalapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Ronald W.","family":"Milam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Niklas","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle T.","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v4.i6.231"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.233"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopthalmol.2011.1846"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.01.028"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-7155"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20130801-01"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.040"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2009.63"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.01.014"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318275394a"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2006.05.005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11765"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.01.026"},{"key":"e_1_3_2_15_2","first-page":"233","article-title":"Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial","volume":"102","author":"Good WV","year":"2004","unstructured":"Good WVEarly Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233\u2013248; discussion 248\u2013250.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4403"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2010.11.016"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2013.02.007"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.06.017"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.5812"}],"container-title":["Ophthalmic Surgery, Lasers and Imaging Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/23258160-20150909-04","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:26:32Z","timestamp":1683069992000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/23258160-20150909-04"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3928\/23258160-20150909-04"],"URL":"https:\/\/doi.org\/10.3928\/23258160-20150909-04","relation":{},"ISSN":["2325-8160","2325-8179"],"issn-type":[{"value":"2325-8160","type":"print"},{"value":"2325-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}